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Aldol reaction of C(3) carbanion of 7-bromo-5-pyrido-1,4-benzodia-
zepin-2-one (1) with representative aliphatic and aromatic aldehy-
des and ketones afforded racemic mixtures syn/anti-7-bromo-3-(1-
hydroxy-1-phenylmethyl)-1-methyl-5-(2-pyridyl)-2,3-dihydro-1H-
1,4-benzodiazepin-2-one (2/3), syn/anti-7-bromo-3-(1-hydroxy-1-phe-
nylethyl)-1-methyl-5-(2-pyridyl)-2,3-dihydro-1H-1,4-benzodiazepin
-2-one (4/5) and syn/anti-7-bromo-3-(1-hydroxy-2-methylpropyl)-
1-methyl-5-(2-pyridyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one (6/7)
with 60–85% diastereoselectivity. For prevailing diastereomeric
racemates ()-2 and ()-4, syn relative configuration is deduced,
whereas the prevailing diastereomer ()-7 has anti configuration.
Configurational assignment is based on 1H NMR data and X-ray
structure analysis, and the origin of inversion of diastereoselec-
tivity is discussed. Racemic mixtures were separated on chiral
HPLC column, and on the basis of the CD spectra (3R) absolute
configuration was determined for (+)-enantiomers, and (3S) configu-
ration for (–)-enantiomers. Consequently, (3R,1S) configuration is
assigned to syn-(+)-enantiomers and (3R,1R)-configuration to anti-
(+)-enantiomers. In an attempt to use enantiomerically pure com-
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pounds 2–7 as catalysts in asymmetric alkylation of benzaldehyde
by diethylzinc, these ligands proved chemically and configuration-
ally unstable.
Key words: 1,4-benzodiazepines, enantioseparation, HPLC chiral
chromatography, relative and absolute configuration.
INTRODUCTION
Rational design and synthesis of novel chiral molecules directed towards
asymmetric synthesis or asymmetric molecular recognition is one of the
most important goals in modern organic chemistry. In this context, a great
number of enantiomerically pure compounds (EPC), or homochiral mole-
cules, containing heteroatoms such as nitrogen, oxygen, sulphur or phospho-
rus as electron-pair donors, have been developed as asymmetric control-
lers.1–3 These molecules are particularly effective in enantioselective (asym-
metric) syntheses when applied as chiral ligands in catalytic organometallic
complexes.4–6 Such complexes catalyze a wide variety of reactions, though
formation of a C–C bond in enantioselective fashion still represents one of
the principal targets in this field.7,8
We have recently reported successful lipase catalyzed kinetic resolution
of racemic 3-substituted-5-phenyl-1,4-benzodiazepines of the general formu-
lae Ib–d,9,10 and we have also completed a study of diastereoselective aldol
reaction of the carbanion of the parent unsubstituted compound Ia.11
Prompted by these results, we have undertaken a study of the aldol re-
action of 7-bromo-5-pyrido-1,4-benzodiazepin-2-one (1) in order to achieve
diastereoselectivity in this reaction, separate syn/anti diastereomeric ra-
cemates, and subsequently resolve, by the lipase catalyzed kinetic resolu-
tion,9,10 single enantiomers of each racemic mixture. Enantiomerically pure
target compounds are envisaged as tridentate (N,N,O) ligands in catalytic
organometallic complexes, as potentially biologically active compounds or
their intermediates.
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Herein we report the results of this synthetic study, as well as the deter-
mination of relative and absolute configuration of single enantiomers, as well
as the first attempt to use some of these homochiral molecules as catalytic
tridentate ligands in asymmetric alkylation of benzaldehyde by diethylzinc.
RESULTS AND DISCUSSION
Synthesis and Diastereoselectivity
Carbanion was generated by addition of compound 1 onto the in situ
prepared lithium-diisopropylamide (LDA) at –78 °C. Its formation, and con-
sumption on addition of carbonyl compound can be easily monitored by the
appearance and disappearance of deep-red color in solution. Benzaldehyde,
acetophenone or isobutyraldehyde were used as the carbonyl counterpart in
aldol reaction, Scheme 1; preparative results are given in Table I.
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Scheme 1.
TABLE I
Aldol reaction of 5-pyrido-1,4-benzodiazepin-2-one 1
Products R,R1CO HPLC
ratioa
Yield
R R1 %
2/3
4/5
6/7
Ph
Ph
i-Pr
H
CH3
H
80 : 20
80 : 20
7 : 93
68
44
50
a First eluated syn-isomer, second eluated anti-isomer.
Diastereoselectivity of the aldol reaction of 1 with a representative aro-
matic aldehyde and ketone was nearly the same, and notably lower than
with aliphatic aldehyde. Interestingly, the direction of diastereoselectivity
for 2/3 and 4/5 is opposite to that for 6/7, and to that observed11 for 5-phenyl
congener (Ia) in reactions with a series of aromatic and aliphatic aldehydes.
This indicates that enolate derived from 1 is more reactive than that de-
rived from Ia, and it follows from the observation that compound 1 is more
reactive than Ia in the aldol reaction with formaldehyde, the least crowded
aldehyde.9a Fast formation of disubstituted 3,3-dihydroxymethyl derivative
of 1 was observed,12 which either reflects higher reactivity of its enolate as
compared to Ia, or the reversibility of aldol reaction, which is common for
stabilized enolates.13
Two diastereomeric racemates, ()-2 and ()-3, were obainted by chro-
matographic separation on silica gel column, whereas for the other two
pairs, 4/5 and 6/7, only the prevailing diastereomers ()-4 and ()-7 were
isolated for further studies. According to the Karplus equation,14a,b syn con-
figuration can be assigned to compound 2 Ja,b = 4.5 Hz, and Ha–C–C–Hb di-
hedral angle of ca. 40°, whereas compound 3 exhibits twice as large Ja,b con-
stant (9.0 Hz), and possesses anti configuration with a ca. 160° Ha–C–C–Hb
dihedral angle. Analogous syn/anti assignment for diastereomeric racema-
tes Ie and If was confirmed in a straightforward way by X-ray structure
analysis.11 Correlation of relative NMR data for ()-2 and ()-3 with those of
If and Ie, for which relative configurations are determined by X-ray struc-
ture analysis, strongly supports the assignment of their respective syn and
anti configurations.
The results with 5-pyrido-1,4-benzodiazepine 1 points to the conclusion
that the prevailing syn diastereomers ()-2, ()-4 and anti diastereomer
()-7 are products of the kinetic control, Scheme 2. Cyclic syn TS‡ is charac-
terized by the -systems overlap when R = Ph, and more crowding if R =
i-Bu than Ph, but if there is Me in place of Hb (acetophenone), there is no
more crowding, though open-chain mechanims also preferentally lead to the
syn product.13 Cyclic anti TS‡ is characterised by the absence of -overlap
when R = Ph, and less crowding if there is i-Bu than Ph, but if there is Me
in place of Hb, there is more crowding. Assuming the kinetic control of
syn/anti diastereomeric ratio 4/5, and higher steric congestion of the phenyl
over methyl group, as recently confirmed also by CD spectroscopy,21 syn con-
figuration can be deduced for the prevailing diastereomer ()-4, and anti for
minor diastereomer ()-5.
Definite proof of relative syn configuration for the prevailing diastereo-
meric racemate ()-4 and anti configuration for ()-7 came from their X-ray
structure analysis (described below).
710 M. MAJERI]-ELENKOV ET AL.
Description of the Molecular and Crystal Structures of 4 and 7
The structures of 4 and 7 with the atom numbering and intramolecular
hydrogen bonds are shown in Figures 1 and 2. Hydrogen bonds are listed in
Table II. Hydrogen bond pattern in the crystal packing of 7 is shown in Fig-
ure 3.
Both crystal structures are racemic mixtures: (3R,12S) and (3S,12R) were
encountered in 4, whereas (3R,12R) and (3S,12S) enantiomers were found in
7. However, 4 crystallizes in the triclinic noncentrosymmetric space group
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Scheme 2.
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Figure 1. ORTEP29 of 4 (A and B) with the atom numbering. Intramolecular hydro-
gen bond is shown. Thermal ellipsoides are scaled at the 20% level.
Figure 2. ORTEP view of 7 with the atom numbering. Intramolecular hydrogen bond
is shown. Thermal ellipsoides are scaled at the 30% level.
with two crystalographically independent molecules A and B. In the crystal,
these two molecules reveal slightly different conformations, Table III. 1,4-
Benzodiazepin-2-one rings reveal a boat conformation with an approximate
Cs symmetry.
In compound 4, the relative configuration about the bond C3–C12 con-
necting two stereogenic centers of different absolute configurations (3R,12S
and its enantiomeric pair) is syn O13–C12–C3–N4, –66.3(7)° for A, and
64.6(7) for B. In compound 7, C3–C12 bond connects two stereogenic cen-
ters of the same absolute configuration (3R,12R and its enantiomeric pair)
and the relative configuration is anti O13–C12–C3–N4, 176.8(6)°. Never-
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TABLE II
Hydrogen bonds in the crystals of 4 and 7a,b
DA / Å D–H / Å HA / Å D–HA / °
Symmetry
oper. on A
4
O13–H13O11 2.742(9) 0.820 2.064 139.85 –
O13–H13O11 2.718(9) 0.820 2.062 136.72 –
7
O13–H13–O11 2.888(8) 0.820 2.537 107.21 –
O13–H13–O11i 2.814(8) 0.820 2.082 148.40 –x, 1–y, –z
a D, donor; A, acceptor.
b Estimated standard deviations given in parentheses.
TABLE III
Selected torsional angles / ° in 4a,b
A B
C14–C12–C15–C20 –61.6(10) –123.1(8)
C14–C12–C15–C16 119.7(8) 58.9(10)
O13–C12–C15–C20 179.0(8) –3.8(9)
C3–C12–C15–C16 –118.9(8) –62.2(10)
O13–C12–C15–C16 0.3(10) 178.2(7)
C3–C12–C15–C20 59.8(10) 115.8(8)
a A, B; crystallographically independent molecules.
b Estimated standard deviations given in parentheses.
theless, the proton donor groups (hydroxyl O13–H) in both compounds are
oriented towards carbonyl O11, and the intramolecular hydrogen bond is
formed. In addition, hydroxyl O13–H in 7 acts also as a donor in an inter-
molecular hydrogen bond to a carbonyl oxygen in the neighboring molecule,
thus forming a centrosymmetric dimer through bifurcated hydrogen bond-
ing arrangement. These dimers are connected into an infinite chain through
a weak C–HBr interaction (BrH20 3.219 Å), Figure 3.
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Figure 3. Crystal packing of 7. Dimers related by an inversion symmetry through
OHO hydrogen bonds are connected into an infinite chain through a weak
C–HBr interaction (symmetry code II; 0.5–x, y–0.5, 1–z).
Resolution and Absolute Configuration of the Enantiomers
All attempts at lipase catalyzed kinetic resolution of the chromatogra-
phically separated racemic mixtures 2–4 and 7 have failed. Out of ca. 30 mi-
crobial and fungal lipases previously tested in enantioselective acetylation
of rac 5-phenyl-3-hydroxymethyl-1,4-benzodiazepines,9,10 nine have been se-
lected for screening; Pseudomonas cepacia, Pseudomonas species, Pseudomo-
nas fluorescens, Candida cylindracea, Lipozym IM, Novozym 435, Asper-
gillus niger, Penicillium cammemberti, and pig pancreas lipase. No lipase
proved active in acetylation of 2–4 and 7. Large steric crowd in these sec-
ondary and tertiary alcohols seems to be the origin of the failed acceptance
by lipases, since highly effective resolution was achieved by acetylation of
Ib,9 and moderately enantioselective acetylation of Ic and Id,10 by Mucor
mieihei lipase (Lipozyme IM),9 and Candida antarctica (Novozym 435) lipa-
se,10b respectively.
Enantioseparation was then attempted by screening some commercial
and in-house prepared chiral HPLC columns,16a,b,17 and Chiralpak AS col-
umn was selected as the most effective. This column separated all racema-
tes to the base line and proved useful for preparative separation of enantio-
mers on the milligram scale, see Experimental. It is interesting to note that
(–)-enantiomers of syn diastereomers 2 and 4 were slower running on this
chiral column, whereas (+)-enantiomer of anti diastereomer 7 was slower
running. This is not surprising in view of the structure of the chiral station-
ary phase in Chiralpak AS column; it comprises amylose carbamate of
(+)-phenylethylisocyanate, which provides a number of carbamate groups
with phenyl ring on the stereogenic center, contributing to chiral recogni-
tion.17 In 2 and 4, the aromatic systems are syn and shield one -face of
each other, and therefore they offer less -interaction space for the phenyl
rings of phenylcarbamate moiety than 7, where all -faces are exposed to
the chiral phase in the column.
Slower running enantiomers were taken for chiroptical studies, and the
faster running ones were used as ligands in the catalytic experiments. In or-
der to determine the absolute configuration of all stereoisomers, CD spectra
of the slower running enantiomers of 2–4 and 7 were determined, Figure 4.
As repeatedly shown by us,18a,b and others,19,20 the absolute configura-
tion at the stereogenic center (C3) can be deduced for 3-substituted 1,4-ben-
zodiazepines from their CD spectra. For (–)-2, a strong positive Cotton effect
(bisignate curve or couplet), with negative and positive extrema at 260 nm
and 234 nm, is observed. Since the large (C3)–CH(OH)Ph group is placed in
pseudoeqautorial position, and coupled chromophores possess M-absolute
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conformation, (3R) absolute configuration can be deduced with complete
confidence by observing the stereoformula or Dreiding model.*
In the same way, the absolute configuration at (C3) for (+)-3 and (+)-7 is
assigned as (3S), for (–)-4 as (3R). Since for (–)-2 and (+)-3 relative configu-
ration is already determined as anti and syn, respectively, assignment of the
absolute configuration at (C3) reveals absolute configuration at the second
stereogenic center; it is (C12S) for (–)-2 and also (C12S) for (+)-3. Following
the same argumentation, absolute configuration of (–)-4 is assigned as
(C3R,C12R), of (+)-5 as (C3S,C12S), and of (+)-7 as (C3S,C12S).
It is interesting, however, that CD couplets of (–)-2 and (+)-3, which
have opposite configurations at (C3) and the same at (C12), exhibit ampli-
tudes, i.e. A-values (A = 1max – 2max),
21 that differ in intensity by ca.
10%; A for (–)-2 and (+)-3 amounting is –42.3 and +46.6, respectively. Since
in the syn diastereomer, rotation around (C3)–(C12) bond is more restricted
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* Note. In this paper we now use, contrary to the common practice in our previous papers,18a–c
and those of other authors,19a–d atoms N(1)–C(2)–C(3)–N(4) instead of C(2)–C(3)–N(4)–C(5) to
define the torsional angle , Figure 5. According to the present selection, which is in accord
with the CIP priority rules, stable absolute conformation of (3R) enantiomers with the larger
substituent in psudoequatorial position is M, while according to the other selection, introduced
by the late Prof. G. Snatzke and used by all previous authors, it was assigned as P.20
Figure 4. CD spectra of (–)-2, (+)-3, (–)-4, (+)-5 and (+)-7, in MeCN.
by stronger intramolecular hydrogen bonding (C12)–OHO=C, it presum-
ably allows another exciton interaction between phenyl groups on (C12) and
(C5) atoms. Observation of dreiding models reveals the positive sign of this
interaction, which offers a tentative explanation for compensation of the
negative CE in the CD of (–)-2.
We have tested optically pure compounds as chiral 1,4-N,O-ligands in
enantioselective alkylation of benzaldehyde by Et2Zn, Scheme 3.
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Figure 5. Assignment of M/P configuration of 1,4-benzodiazepines according to the
CIP priority rules.
Scheme 3.
First, we repeated the protocol with (1R,2S)-N-methyl ephedrine as
bidentate ligand; 68% e.e. of 1-phenylpropanol at 90% conversion was ob-
tained, as compared to the published data: 64% e.e. at 66% conversion.22
The results with new ligands were quite disappointing, however; alkylation
was slow, 20–40% of benzylalcohol was formed as a side-product; enantio-
selectivity was 20% with (–)-2, 14% with (+)-3, and negligible with (–)-4 and
(+)-7. The origin of the poor catalytic activity of these ligands was traced
when stability of the selected ligand (–)-2 was tested in the presence of Et2Zn
in toluene; enantiomeric purity diminished to 90% after 2 h stirring at 0 °C,
and dropped down to 56% after 70 h, accompanied by intensive chemical de-
composition. Presumably, Et2Zn acts as a strong base, causing a retro-aldol
reaction and racemization via enolization. In this context it is worth notic-
ing that the only bidentate ligand with an amide group as yet used in
alkylation by Et2Zn comprises the neopentyl unit (CH3)3C–CONR2, i.e. no
C–H acidic proton is present on the -carbon of the amide carbonyl group.23
Since optically pure enantiomers of 2 and 3 can be hydrolyzed without
loss of optical purity, as we have recently reported on similar racemic sub-
strates,11 the results reported here offer a new approach to all four enantio-
mers of phenylserine, -amino--hydroxy acid that plays an essential role as
a chiral synthetic building block.24
In conclusion, a number of enantiomerically pure derivatives of 3-substi-
tuted 5-pyrido-1,4-benzodiazepin-2-one were prepared on the milligram scale,
thermodynamic control of diastereoselectivity was established, and absolute
configuration of all enantiomers separated using chiral HPLC was determined.
If non-chromatographic resolution could be completed, these compounds
would be useful intermediates in preparation of -amino -hydroxy acids.
They proved unstable in the presence of the strong base Et2Zn when enantio-
selective alkylation of benzaldehyde was attempted. Preparation of their
2-deoxy congeners avoiding the lactame carbonyl group is envisaged, expect-
ing their high configurational stability eliminating enolization, and better
enantioselectivity in asymmetric alkylation.
EXPERIMENTAL
General
IR spectra were run on a Perkin Elmer 297 spectrometer for KBr pallets. 1H and
13C NMR spectra were obtained with a Varian Gemini XL 300 spectrometer in CDCl3
solutions,  is given in ppm relative to TMS as internal reference, and J in Hz. HPLC
chromatography was performed on a HP 1050 chromatograph with NucleosilC18 RP
(Supelco, 250 	 4.6 mm) reverse phase column, separation was monitored by a HP
1050 UV detector set at 254 nm and connected to a HP 3396A integrator. Enatiomeric
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excess (e.e.) was determined for 3, 4, 5, and 7 on a chiral OD-R column (Diacel Co.),
using various ratios of 0.5 M NaClO4/HClO4 (pH = 2) : MeOH. M.p.s were determined
on Electrothermal Apparatus, and are not corrected. Optical rotations were obtained
with Optical Activity AA-10 Automatic Polarimeter in a 1 dm cell; c given in g/100 ml.
CD-Spectra were run on a Jasco J-810 spectropolarimeter.
Elemental analyses were performed either by HR/MS, on an Extrel-FTMS 2001DD
instrument, or by the combustion method; in both cases HPLC purity of analytical
samples was 
 99.5%.
All commercial reagents were used as received.
Aldol Reaction of 1. General Procedure
To the solution of (i-Pr)2NH (1.65 ml, 12 mmol) in dry THF (20.0 ml), 2.5 M solu-
tion of n-BuLi in n-hexane (4.7 ml, 12 mmol) was added under argon at 0 °C. After
15 min stirring at –78 °C, the solution of 1 (3.0 g, 9.1 mmol) in THF (20.0 ml) was
added, and after 30 min of stirring, benzaldehyde (2.5 g, 22.0 mmol) was added. Af-
ter 1 h of stirring, reaction was quenched by addition of 5% aq. hydrochloric acid, ad-
justing pH to 5–6. Then, the reaction mixture was extracted with CH2Cl2 (3 	50 ml),
organic extracts were dried over Na2SO4 and evaporated in vacuo on a Büchi rotary
evaporator. Diastereomeric ratio 2/3 (80 : 20, at 96% conversion) was determined us-
ing the mobile phase MeOH/H2O (1:1), at a flow rate of 0.8 ml/min. Crude product
was crystallized from CH2Cl2/(i-PrO)2O affording 2.6 g (53%) of pure diastereomer 2.
Mother liquors were evaporated and anti isomer was isolated by column chromato-
graphy on silicagel (100 g) with CH2Cl2/(i-PrO)2O/MeOH/Et3N (50 : 50 : 5.0 : 0.5) as
eluent; 0.57 g (15%) of pure isomer 3 was obtained.
syn-7-Bromo-3-(1-hydroxy-1-phenylmethyl)-1-methyl-5-(2-pyridyl)-2,3-
dihydro-1H-1,4-benzodiazepin-2-one (2)
M.p. 213–214 °C (decc.). IR max/cm–1: 3400, 1670, 1400, 110, 830, 700. 1H NMR
/ppm: 3.36 (3H, s), 3.79 (1H, d, J = 4.6 Hz), 4.53 (1H, bs), 5.50 (1H, d, J = 4.4 Hz),
7.19 (1H, d, J = 8.7 Hz), 7.24–7.38 (4H, m), 7.44 (1H, d, J = 2.2 Hz), 7.53 (2H, d, J =
7.2 Hz), 7.62 (1H, dd, J1 = 8.7 Hz, J2 = 2.3 Hz), 7.82 (1H, dt, J1 = 7.8 Hz, J2 = 1.8
Hz), 8.10 (1H, d, J = 8.0 Hz), 8.58 (1H, dd, J1 = 4.1 Hz, J2 = 0.8 Hz). 13C NMR /ppm:
35.0, 68.1, 72.3, 117.0, 123.2, 123.9, 124.9, 127.3, 127.5, 128.0, 129.4, 133.4, 134.4,
136.9, 140.8, 142.1, 148.6, 155.2, 167.2, 169.5. HR/MS m/z calcd. for C22H18N3O2Br+H+
(M-H+): 436.0655; found: 436.0592.
Ca. 30 mg of ()-2 was separated on Chiralpak AS column with n-hexane/i-propanol
(25 : 75) as eluent. Rt for (+)-2: 21.7 min, Rt for (–)-2: 31.4 min, D = – 81.8 (c = 0.22
g/100 ml, CHCl3).
anti-7-Bromo-3-(1-hydroxy-1-phenylmethyl)-1-methyl-5-(2-pyridyl)-2,3-
dihydro-1H-1,4-benzodiazepin-2-one (3)
M.p. 111–113 °C. IR max/cm–1: 3450, 1670, 1400, 1330, 1110, 700. 1H NMR /ppm:
3.43 (3H, s), 3.73 (1H, d, J = 9.0 Hz), 3.99 (1H, bs), 5.71 (1H, d, J = 9.0 Hz), 7.23
(1H, d, J = 9.0 Hz), 7.28–7.36 (5H, m), 7.50–7.53 (2H, m), 7.62 (1H, dd, J1 = 9.0 Hz,
J2 = 2.3 Hz), 7.75 (1H, dt, J1 = 7.7 Hz, J2 = 1.3 Hz), 7.87 (1H, d, J = 7.7 Hz), 8.55 (1H,
d, J = 4.3 Hz). 13C NMR /ppm: 35.1, 69.2, 73.8, 117.0, 123.1, 123.8, 124.7, 127.3,
DIASTEREOSELECTIVE ALDOL REACTIONS 719
127.6, 128.0, 129.3, 133.4, 134.3, 136.8, 140.6, 142.1, 148.5, 155.3, 165.8, 170.4. HR/MS
m/z calcd. for C22H18N3O2Br+H+ (M-H+): 436.0655; found: 436.0654.
Ca. 30 mg of ()-3 was separated on Chiralpak AS column with n-hexane/i-propanol
(25 : 75) as eluent. Rt for (–)-3: 12.2 min, Rt for (+)-3: 16.3 min, D = +161 (c = 0.14
g/100 ml CHCl3).
syn-7-Bromo-3-(1-hydroxy-1-phenylethyl)-1-methyl-5-(2-pyridyl)-2,3-
dihydro-1H-1,4-benzodiazepin-2-one (4)
Starting from 1 (1.0 g, 3.0 mmol) and acetophenone (0.36 g, 3.0 mmol), the reaction
was performed as described above. At 60% conversion, the reaction was quenched
and the crude product was purified using the same chromatographic conditions as
described above. 405 mg of mixture 4/5 and 190 mg of pure 4 was obtained; yield
44%. M.p. 201–203 °C (decc). IR max/cm–1: 3460, 1660, 1330, 1110, 880, 700. 1H NMR
/ppm: 1.80 (s, 3H), 3.43 (3H, s), 3.79 (1H, s), 5.52 (1H, bs), 7.21–7.38 (7H, m), 7.49–7.57
(2H, m), 7.65–7.71 (2H, m), 8.52 (1H, dd, J1 = 4.6 Hz, J2 = 0.5 Hz). 13C NMR /ppm:
27.6, 35.2, 69.6, 74.8, 117.4, 123.5, 124.3, 124.8, 125.7, 126.5, 127.9, 129.4, 133.4, 134.5,
137.0, 142.2, 145.6, 148.4, 155.5, 166.5, 170.0.
Anal. calcd. for C23H20N3O2Br (Mr = 450.33): C 61.34, H 4.48, N 9.33%; found: C
61.82, H 4.88, N 9.36%.
Ca. 30 mg of ()-4 was separated on Chiralpak AS column with n-hexane/i-propanol
(15 : 85) as eluent. Rt for (+)-4: 12.4 min, Rt for (–)-4: 19.7 min, D = –158 (c = 0.31
g/100 ml CHCl3).
anti-7-Bromo-3-(1-hydroxy-2-methylpropyl)-1-methyl-5-(2-pyridyl)-2,3-
dihydro-1H-1,4-benzodiazepin-2-one (7)
Starting from 1 (1.0 g, 3.0 mmol) and isobutyraldehyde (0.48 ml, 3.0 mmol), the
reaction was completed in 30 min at –78 °C. Crude product was separated and puri-
fied using standard chromatographic conditions to give 230 mg mixture of 6/7 and
440 mg of pure 7; yield 50%, m.p. 185–187 °C (decc). IR max/cm–1: 3450, 1670, 1330,
820, 700. 1H NMR /ppm: 0.98 (d, 3H), J = 6.7 Hz), 1.04 (3H, d, J = 6.4 Hz), 1.34 (1H,
m), 1.54 (1H, m), 2.01 (1H, m), 3.39 (3H, s), 3.41 (1H, d, J = 6.5 Hz), 4.66 (1H, m),
7.22 (1H, d, J = 9.0 Hz), 7.37 (1H, m), 7.53 (1H, s), 7.64 (1H, d, J = 8.7 Hz), 7.83 (1H,
t, J = 7.7 Hz), 8.15 (1H, d, J = 7.9 Hz), 8.60 (1H, d, J = 4.3 Hz). 13C NMR /ppm: 21.6,
23.9, 24.2, 34.9, 42.2, 68.6, 69.9, 117.0, 123.2, 123.7, 124.8, 129.7, 133.4, 134.4, 136.9,
142.3, 148.7, 155.3, 166.0, 170.7.
Anal. calcd. for C20H22N3O2Br (Mr = 416.31): C 57.70, H 5.33, N 10.09; found: C
57.94, H 5.06, N 9.93%.
Ca. 20 mg of ()-7 was separated on Chiralpak AS column with n-hexane/i-propanol
(30 : 70) as eluent. Rt for (–)-7: 7.5 min, Rt for (+)-7: 12.6 min, D = + 164 (c = 0.28
g/100 ml CHCl3).
Catalytic Addition of Zn(Et)2 on Benzaldehyde. General Procedure
1,4-Benzodiazepine ligand (2.5 mmol) was dissolved in abs. dry toluene (0.5 ml)
under argon, and 1 M solution of Zn(Et)2 (1.0 ml, 1.0 mmol) was added. After 15 min
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TABLE IV
Crystallographic data, structure solution and refinement of compounds 4 and 7
4 7
Molecular formula C23H20N3O2Br C20H22N3O2Br
Mr 450.32 416.31
Crystal system triclinic monoclinic
Space group P1 P21/a
a / Å 8.372 (3) 9.560 (3)
b / Å 10.92 (2) 14.000(2)
c / Å 11.880 (10) 14.685(2)
 / ° 74.40 (10) 90.00
 / ° 84.39(5) 95.96(3)
 / ° 78.56(4) 90.00
V / Å3 1024(2) 1954.2(9)
Z 2 4
F (000) 460 856
Dx / g cm–3 1.461 (4) 1.415(2)
 (Mo-K) / mm–1 2.03 2.12
Absorption correction 	-scan no correction
Total data collected 4388 4315
Unique data 4388 3975
Observed data criterion 2250 I > 2(I) 1026 I > 2(I)
Rint 0.0775 0.0555

max / ° 26.29 26.38
R1 Fo>4(Fo) 0.042 0.060
wR2 (F2), all data 0.1012 0.1473
Goodness of fit, S 0.958 0.863
Number of refined variables 530 240
max, min / e Å–3 0.38, –0.48 0.34, –0.58
Data reduction program HELENA24 HELENA
Structure solution program SIR9725 SIR97
Struct. refinement program SHELXL9726 SHELXL97
Preparation of material for
publication (program)
PLATON9827 PLATON98
stirring at 0 °C, solution of benzaldehyde (52 mg, 0.5 mmol) in abs. toluene (0.5 ml)
was added. After 24 h stirring at ambient temperature, 5.0 ml of 1 M HCl (aq) was
added, the reaction mixture was extracted with CH2Cl2, and the extract was dried
overnight. After evaporation of the solvent, conversion was determined by GC analy-
sis (HP-17 column, temperature gradient 70–150 °C, at 5 °C/min), and e.e. was de-
termined by HPLC (Chirlacel OD-H column, n-hexane/i-PrOH (95 : 5) as mobile
phase).
X-ray Analysis of 4 and 7
Compounds 4 and 7 were crystallized from a mixture of ethanol and dichloro-
methane (vol. ratio 1:1), with a few drops of THF, at 4 °C. Table IV summarizes the
crystal data and experimental details of data collection, refinement and the software
used. The data were corrected for Lorentz and polarization effects. The crystal struc-
ture determination of 4 revealed two molecules (A and B) in the asymmetric unit.
The overall conformations of A and B are slightly different, with the opposite chirality
at the stereogenic centers (S,R and R,S) forming a racemate in the triclinic noncentro-
symmetric space group. All H-atoms were calculated on stereochemical grounds and
subsequently refined using the SHELXL riding model. Atomic scattering factors and
anomalous dispersion values for bromine were those included in SHELX97.
Supplementary materials. – Crystallographic data (excluding structure factors)
for the structures reported in this paper have been deposited with the Cambridge
Crystallographic Data Centre at deposition Nos. CCDC-159563 and CCDC-159564.
Copies of the data can be obtained, free of charge, on application to the CCDC, 12
Union Road, Cambridge CB2 1EZ UK (fax: +44(1223)336033; e-mail: deposit@ccdc.
cam.ac.uk).
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SA@ETAK
Dijastereoselektivna aldolska reakcija
7-brom-5-pirido-1,4-benzodiazepin-2-ona; relativne i apsolutne
konfiguracije svih stereoizomera
Maja Majeri}-Elenkov, Dinko @iher, Aleksandar Vi{njevac, Zdenko Hamer{ak,
Biserka Koji}-Prodi} i Vitomir [unji}
Aldolska reakcija C(3) karbaniona 7-brom-5-pirido-1,4-benzodiazepin-2-ona (1) s
predstavnicima alifatskih i aromatskih aldehida i ketona dala je racemi~ne smjese
syn/anti-7-brom-3-(1-hidroksi-1-fenilmetil)-1-metil-5-(2-piridil)-2,3-dihidro-1H-1,4-
benzodiazepin-2-ona (2/3), syn/anti-7-brom-3-(1-hidroksi-1-feniletil)-1-metil-5-(2-
piridil)-2,3-dihidro-1H-1,4-benzodiazepin-2-ona (4/5) i syn/anti-7-brom-3-(1-hidroksi-
2-metilpropil)-1-metil-5-(2-piridil)-2,3-dihidro-1H-1,4-benzodiazepin-2-ona (6/7) s
60–85%-tnom dijastereoselektivno{}u. Utvr|ena je syn relativna konfiguracija za
prete`no nastale dijastereomere racemata ()-2 i ()-4, dok prete`ni dijastereomer
()-7 posjeduje anti-konfiguraciju. Odre|ivanje konfiguracije zasnovano je na poda-
cima 1H NMR i kristalografske strukturne analize, i razmatra se uzrok inverzije
dijastereoselektivnosti. Enantiomeri su razdvojeni na kiralnim HPLC kolonama. Na
temelju spektara CD odre|ena je apsolutna konfiguracija (3R) za (+)-enantiomere, a
konfiguracija (3S) za (–)-enantiomere. Prema tome, konfiguracija anti-(+)-enantio-
mera je (3R,1'S), a konfiguracija syn-(+)-enantiomera je (3R,1'R). Pri poku{aju pri-
mjene enantiomerno ~istih spojeva 2–7 kao katalizatora za enantioselektivnu alkil-
aciju benzaldehida dietilcinkom, ti su se ligandi pokazali kemijski i konfiguracijski
nestabilnima.
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